A CRISPR focus on attitudes and beliefs toward somatic genome editing from stakeholders within the sickle cell disease community

PURPOSE: Genome editing holds both tremendous therapeutic promise and significant potential risk. Sickle cell disease (SCD), the most commonly inherited blood disorder, is a frontline candidate for the clinical applications of this tool. However, there is limited knowledge of patient community value...

Descripción completa

Detalles Bibliográficos
Autores principales: Persaud, Anitra, Desine, Stacy, Blizinsky, Katherine, Bonham, Vence L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606394/
https://www.ncbi.nlm.nih.gov/pubmed/30581191
http://dx.doi.org/10.1038/s41436-018-0409-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606394/
https://www.ncbi.nlm.nih.gov/pubmed/30581191
http://dx.doi.org/10.1038/s41436-018-0409-6

Ejemplares similares